Kleo Pharmaceuticals Presents Preclinical Proof-of-Concept Data on a Novel Chemical Conjugation Platform (MATE™) at the Society for Immunotherapy of Cancer's (SITC) 35th Annual Meeting
November 09, 2020 08:00 ET
|
Kleo Pharmaceuticals
NEW HAVEN, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Kleo Pharmaceuticals, Inc., a targeted immunotherapy company developing fully synthetic bispecific therapies to redirect, enhance or replace...
Rubius Therapeutics Presents Preclinical Data for Lead Red Cell Therapeutic™ Clinical Oncology Program, RTX-240, at the Society for Immunotherapy of Cancer’s Annual Meeting
November 09, 2020 08:00 ET
|
Rubius Therapeutics
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
AMMO, Inc. Sees Demand Increase 291% for Its Streak Visual Ammunition Year Over Year
November 09, 2020 08:00 ET
|
AMMO, Inc.
SCOTTSDALE, AZ, Nov. 09, 2020 (GLOBE NEWSWIRE) -- AMMO, Inc. (OTCQB: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, is...
ASML reports transactions under its current share buyback program
November 09, 2020 08:00 ET
|
ASML Netherlands BV
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share...
Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
November 09, 2020 08:00 ET
|
Iovance Biotherapeutics, Inc.
44.4% Overall Response Rate (ORR) and Median Duration of Response (DOR) Not Reached at 8.6 Months of Study Follow Up First Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy in Combination...
ZAGENO Doubles Engineering to Support High-Paced, Customer-Centric Operating Model Under Leadership of New VP of Engineering
November 09, 2020 08:00 ET
|
ZAGENO
CAMBRIDGE, Mass. and BERLIN, Germany and WROCLAW, Poland, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ZAGENO, a leading enterprise marketplace solution connecting eCommerce to life science, today...
Jounce Therapeutics to Participate in a Virtual Fireside Chat at Cowen 2020 IO Next Summit
November 09, 2020 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Cerence to Announce Fourth Quarter and Full Fiscal Year Results on November 16, 2020
November 09, 2020 08:00 ET
|
Cerence Inc.
BURLINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, will announce its fourth quarter and full fiscal year 2020 financial results for the year...
Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
November 09, 2020 08:00 ET
|
Myriad Genetics, Inc.
Highlights: Revenue of $145.2 million up 56% sequentially in quarter ended Sept. 30, 2020GAAP operating income increased $28.7 million sequentially; non-GAAP operating income increased $30.2...
IMMINENT SHAREHOLDER DEADLINE: Nikola Corp. Sued by Block & Leviton LLP for Securities Fraud; Investors Who Lost Money Should Contact the Firm
November 09, 2020 08:00 ET
|
Block & Leviton LLP
BOSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class lawsuit on behalf of...
- May 18, 2024 17:16 ET MenuSifu announces restaurant automation partnership with Happy Cashier and Hestia at NRA 2024
- May 18, 2024 10:18 ET Credit Card Compare Announces Credit Card Product Data API Tool